Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “AXSOME THERAPEUTICS, INC.”

127 pharma patents match "AXSOME THERAPEUTICS, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 127
Index total 30,257
Page 3 / 6

Quick answer

This filtered view shows 127 pharmaceutical patents matching "AXSOME THERAPEUTICS, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

127 results for “AXSOME THERAPEUTICS, INC.” · 30,257 patents in full index Clear search

  1. US 11285214

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Mar 29, 2022 · Expires Mar 24, 2042

    granted

  2. US 11285215

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Mar 29, 2022 · Expires Mar 24, 2042

    granted

  3. US 11285213

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Mar 29, 2022 · Expires Mar 24, 2042

    granted

  4. US 11266657

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Mar 8, 2022 · Expires Mar 3, 2042

    granted

  5. US 11219626

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Jan 11, 2022 · Expires Jan 6, 2042

    granted

  6. US 11207328

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted

  7. US 11207327

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted

  8. US 11185547

    Use of reboxetine to treat narcolepsy

    AXSOME THERAPEUTICS, INC. · Granted Nov 30, 2021 · Expires Nov 25, 2041

    granted

  9. US 11185550

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Nov 30, 2021 · Expires Nov 25, 2041

    granted

  10. US 11179352

    Dosage forms and methods for enantiomerically enriched or pure bupropion

    AXSOME THERAPEUTICS, INC. · Granted Nov 23, 2021 · Expires Nov 18, 2041

    granted

  11. US 11179351

    Dosage forms and methods for enantiomerically enriched or pure bupropion

    AXSOME THERAPEUTICS, INC. · Granted Nov 23, 2021 · Expires Nov 18, 2041

    granted

  12. US 11135295

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Oct 5, 2021 · Expires Sep 30, 2041

    granted

  13. US 11135226

    Use of reboxetine to treat narcolepsy

    AXSOME THERAPEUTICS, INC. · Granted Oct 5, 2021 · Expires Sep 30, 2041

    granted

  14. US 11129895

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted

  15. US 11129826

    Bupropion as a modulator of drug activity

    AXSOME THERAPEUTICS, INC. · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted

  16. US 11123431

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Sep 21, 2021 · Expires Sep 16, 2041

    granted

  17. US 11123344

    Bupropion as a modulator of drug activity

    AXSOME THERAPEUTICS, INC. · Granted Sep 21, 2021 · Expires Sep 16, 2041

    granted

  18. US 11110173

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted

  19. US 11077117

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Aug 3, 2021 · Expires Jul 29, 2041

    granted

  20. US 11045549

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Jun 29, 2021 · Expires Jun 24, 2041

    granted

  21. US 11020483

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Jun 1, 2021 · Expires May 27, 2041

    granted

  22. US 11020402

    Use of reboxetine to treat narcolepsy

    AXSOME THERAPEUTICS, INC. · Granted Jun 1, 2021 · Expires May 27, 2041

    granted

  23. US 11013805

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted May 25, 2021 · Expires May 20, 2041

    granted

  24. US 11013806

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted May 25, 2021 · Expires May 20, 2041

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.